A review of infant weaning research from around the world has concluded that the introduction of certain food allergens before the age of 11 months could decrease the likelihood of developing some food allergies.
Read more
DBV Technologies has announced that the FDA has lifted the partial clinical hold on the company’s VITESSE trial.
Read more
The Scottish Medicines Consortium (SMC) has completed its assessment of Arachis hypogaea L., semen (peanuts) (Palforzia®),and have confirmed this is not recommended for use within NHSScotland. They concluded that treatment with Palforzia® is…
Read more
Anaphylaxis UK is deeply saddened to learn of the death of Frans Timmermans, founder of the Dutch Anaphylaxis Network.
Read more
Aimmune Therapeutics has shared its positive findings from the Phase 3 POSEIDON study of Palforzia.
Read more
Following an independent review of hospital food in 2020, the NHS has published new national standards for healthcare food and drink that all NHS organisations will be legally required to meet as…
Read more
We are delighted to welcome Professor John Warner OBE as our Clinical and Scientific Ambassador.
Read more
Following the publication of the Guideline for the diagnosis and management of Pollen Food/Oral Allergy Syndrome, BSACI will be hosting a webinar on Thursday 13 October 5-6pm. Sarah Baker, Anaphylaxis UK’s Head…
Read more